Marstar, have you the slightest inkling of what it takes to bring a new pharmaceutical drug to a chemist near you? Read even a wee-wee bit and your post's value over its absence of any connection with the aforementioned reality of the drugs-to-shelf legal framework, ie. Phases I safety+doage/efficacy+dosage/large cohort or Phase III its will become clearer, ltime (years), costs (millions ++) a year.
OV
PS Joyeux ABCDEFGHIJKMNOPQRSTUVWXYZ!!!!!!!!!!!!
Ann: CYP Advances Towards Osteoarthritis Phase 2 Clinical Trial, page-68
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
-0.010(4.00%) |
Mkt cap ! $43.36M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 25.5¢ | 24.0¢ | $8.739K | 34.96K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 19841 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 50000 | 1 |
View Market Depth
| Last trade - 15.44pm 18/10/2024 (20 minute delay) ? |
| CYP (ASX) Chart |